Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
Objective: The very low-density lipoprotein receptor (VLDLR) plays an important role in the development of hepatic steatosis. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ and fibroblast growth factor 21 (FGF21) in hepatic VLDLR regulation. Methods:...
Main Authors: | Mohammad Zarei, Barroso, Emma, Palomer, Xavier, Dai, Jianli, Rada, Patricia, Quesada-López, Tania, Escolà-Gil, Joan Carles, Cedó, Lidia, Mohammad Reza Zali, Molaei, Mahsa, Dabiri, Reza, Vázquez, Santiago, Pujol, Eugènia, Valverde, Ángela M., Villarroya, Francesc, Liu, Yong, Wahli, Walter, Vázquez-Carrera, Manuel |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/85541 http://hdl.handle.net/10220/45208 |
Similar Items
-
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
by: Mohammad Zarei, et al.
Published: (2018-02-01) -
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2
by: Emma Barroso, et al.
Published: (2020-09-01) -
The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance
by: David Aguilar-Recarte, et al.
Published: (2021-08-01) -
Differential Action of Reelin on Oligomerization of ApoER2 and VLDL Receptor in HEK293 Cells Assessed by Time-Resolved Anisotropy and Fluorescence Lifetime Imaging Microscopy
by: Paula Dlugosz, et al.
Published: (2019-02-01) -
GDF15 mediates the metabolic effects of PPARβ/δ by activating AMPK
by: Aguilar-Recarte, David, et al.
Published: (2021)